Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.
2022
14
Last FY Revenue $0.1M
Last FY EBITDA -$10.3M
$39.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Firefly Neuroscience achieved revenue of $0.1M and an EBITDA of -$10.3M.
Firefly Neuroscience expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Firefly Neuroscience valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $0.1M | XXX | XXX | XXX |
Gross Profit | XXX | $0.1M | XXX | XXX | XXX |
Gross Margin | XXX | 100% | XXX | XXX | XXX |
EBITDA | XXX | -$10.3M | XXX | XXX | XXX |
EBITDA Margin | XXX | -9557% | XXX | XXX | XXX |
EBIT | XXX | -$9.2M | XXX | XXX | XXX |
EBIT Margin | XXX | -8500% | XXX | XXX | XXX |
Net Profit | XXX | -$10.5M | XXX | XXX | XXX |
Net Margin | XXX | -9685% | XXX | XXX | XXX |
Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Firefly Neuroscience's stock price is $3.
Firefly Neuroscience has current market cap of $40.1M, and EV of $39.0M.
See Firefly Neuroscience trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$39.0M | $40.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Firefly Neuroscience has market cap of $40.1M and EV of $39.0M.
Firefly Neuroscience's trades at 361.2x EV/Revenue multiple, and -3.8x EV/EBITDA.
Equity research analysts estimate Firefly Neuroscience's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Firefly Neuroscience's P/E ratio is not available.
See valuation multiples for Firefly Neuroscience and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $40.1M | XXX | $40.1M | XXX | XXX | XXX |
EV (current) | $39.0M | XXX | $39.0M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 361.2x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -3.8x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -4.2x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -3.8x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -5.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialFirefly Neuroscience's revenue per employee in the last FY averaged $8K, while opex per employee averaged $0.7M for the same period.
Firefly Neuroscience's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Firefly Neuroscience's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Firefly Neuroscience and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -9557% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.7M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 1112% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | 1809% | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 8600% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Firefly Neuroscience acquired XXX companies to date.
Last acquisition by Firefly Neuroscience was XXXXXXXX, XXXXX XXXXX XXXXXX . Firefly Neuroscience acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Firefly Neuroscience founded? | Firefly Neuroscience was founded in 2022. |
Where is Firefly Neuroscience headquartered? | Firefly Neuroscience is headquartered in United States of America. |
How many employees does Firefly Neuroscience have? | As of today, Firefly Neuroscience has 14 employees. |
Who is the CEO of Firefly Neuroscience? | Firefly Neuroscience's CEO is Mr. Greg Lipschitz. |
Is Firefly Neuroscience publicy listed? | Yes, Firefly Neuroscience is a public company listed on NAS. |
What is the stock symbol of Firefly Neuroscience? | Firefly Neuroscience trades under AIFF ticker. |
When did Firefly Neuroscience go public? | Firefly Neuroscience went public in 2024. |
Who are competitors of Firefly Neuroscience? | Similar companies to Firefly Neuroscience include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of Firefly Neuroscience? | Firefly Neuroscience's current market cap is $40.1M |
Is Firefly Neuroscience profitable? | Yes, Firefly Neuroscience is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.